Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RASCABG 1
NCT00287209Phase 4Completed
- Sponsor
- Aarhus University
- Start
- Jan 2004
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of amiodarone in Atrial fibrillation (AFib) (2 arms), sponsored by Aarhus University. Primary endpoints: Time to symptomatic atrial fibrillation, cerebral apoplexy/ transitory cerebral infarction (TCI), acute myocardial infarction (AMI), or death at 30 days, Time to symptomatic or asymptomatic atrial fibrillation, cerebral apoplexy/TCI, AMI or death at 30 days and 2 more. Started Jan 2004; status: completed.
02
Drugs
amiodarone
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00287209.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00287209.